These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9722560)

  • 1. Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding.
    Meagher JL; Beechem JM; Olson ST; Gettins PG
    J Biol Chem; 1998 Sep; 273(36):23283-9. PubMed ID: 9722560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of tryptophan 49 in the heparin cofactor activity of human antithrombin III.
    Gettins P; Choay J; Crews BC; Zettlmeiss G
    J Biol Chem; 1992 Oct; 267(30):21946-53. PubMed ID: 1400504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.
    Dementiev A; Swanson R; Roth R; Isetti G; Izaguirre G; Olson ST; Gettins PGW
    J Biol Chem; 2013 Nov; 288(47):33611-33619. PubMed ID: 24068708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the antithrombin III heparin binding site.
    Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
    J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
    Meagher JL; Huntington JA; Fan B; Gettins PG
    J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence analysis of calmodulin mutants containing tryptophan: conformational changes induced by calmodulin-binding peptides from myosin light chain kinase and protein kinase II.
    Chabbert M; Lukas TJ; Watterson DM; Axelsen PH; Prendergast FG
    Biochemistry; 1991 Jul; 30(30):7615-30. PubMed ID: 1854758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III.
    Shah N; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1990 Feb; 57(3):343-52. PubMed ID: 2315891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.